Skip to Content

Xtoro Approval History

FDA Approved: Yes (First approved December 17, 2014)
Brand name: Xtoro
Generic name: finafloxacin
Dosage form: Otic Suspension
Company: Alcon
Treatment for: Otitis Externa

Xtoro (finafloxacin otic suspension) is a fluoroquinolone antimicrobial for the treatment of acute otitis externa, commonly known as swimmer’s ear.

Development History and FDA Approval Process for Xtoro

DateArticle
Dec 17, 2014Approval FDA Approves Xtoro (finafloxacin) Otic Suspension to Treat Swimmer’s Ear

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide